Laura S Schmidt Selected Research

Laura S Schmidt Research Topics

Disease

33	Neoplasms (Cancer) 07/2022 - 12/2003
20	Kidney Neoplasms (Kidney Cancer) 06/2019 - 08/2004
11	Renal Cell Carcinoma (Grawitz Tumor) 07/2022 - 10/2004
7	Carcinogenesis 07/2022 - 05/2005
6	Birt-Hogg-Dube Syndrome 12/2019 - 10/2006
5	Hypoxia (Hypoxemia) 05/2010 - 07/2006
4	Leiomyoma (Uterine Fibroids) 01/2019 - 07/2003
4	Leiomyomatosis 10/2016 - 01/2007
4	Disease Progression 05/2010 - 01/2007
2	Cysts 01/2020 - 10/2006
2	Hemorrhage 01/2019 - 07/2006
1	Familial renal cell carcinoma 01/2021
1	Hyperparathyroidism 2 01/2019
1	Hyperparathyroidism 01/2019
1	Oxyphilic Adenoma (Oncocytoma) 11/2015
1	Margins of Excision 12/2014
1	Cardiomegaly (Heart Hypertrophy) 11/2014
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 09/2010
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 09/2010
1	Tuberous Sclerosis (Bourneville's Disease) 09/2010
1	Lung Diseases (Lung Disease) 09/2010
1	Emphysema 09/2010
1	Body Weight (Weight, Body) 01/2008
1	Reperfusion Injury 01/2008
1	Starvation 10/2006
1	Hamartoma 10/2006
1	Necrosis 07/2006
1	Hereditary leiomyomatosis and renal cell cancer 07/2003

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2005
4	EnzymesIBA 01/2014 - 01/2010
3	Amino Acids FDA Link 11/2020 - 10/2006
3	Sirolimus (Rapamycin)FDA Link 11/2014 - 10/2006
3	Fumarate Hydratase (Fumarase)IBA 01/2014 - 07/2003
3	Messenger RNA (mRNA)IBA 12/2010 - 08/2004
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2020
2	GTP Phosphohydrolases (GTPases)IBA 11/2020 - 10/2015
2	AMP-Activated Protein KinasesIBA 12/2019 - 05/2008
2	IronIBA 01/2019 - 05/2010
2	Oxygen (Dioxygen)IBA 01/2019 - 05/2010
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2016 - 12/2012
2	Mitochondrial DNA (mtDNA)IBA 11/2015 - 09/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2014 - 11/2009
2	TOR Serine-Threonine KinasesIBA 08/2012 - 10/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010 - 10/2004
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 05/2008 - 10/2006
2	Tamoxifen FDA LinkGeneric 01/2008 - 07/2006
1	Nylons (Nylon)IBA 07/2022
1	Etoposide (VP 16)FDA LinkGeneric 07/2022
1	Chlorambucil (Leukeran)FDA Link 07/2022
1	Indicators and Reagents (Reagents)IBA 07/2022
1	Histidine (L-Histidine)FDA Link 01/2021
1	ArsenicIBA 01/2021
1	Microphthalmia-Associated Transcription FactorIBA 01/2021
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	CopperIBA 01/2021
1	CadmiumIBA 01/2021
1	MetalsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	malic acid (malate)IBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	NucleotidesIBA 01/2020
1	CarcinogensIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 06/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Initiator Codon (Start Codon)IBA 01/2019
1	rab GTP-Binding ProteinsIBA 01/2018
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 11/2015
1	ElementsIBA 11/2014
1	Protein Kinases (Protein Kinase)IBA 09/2013
1	trans-sodium crocetinate (crocetin)IBA 09/2010
1	Vascular Endothelial Growth Factor DIBA 09/2010
1	lipoarabinomannan (LAM)IBA 09/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2010
1	UbiquitinIBA 01/2010
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2009
1	Sorafenib (BAY 43-9006)FDA Link 05/2009
1	Sunitinib (Sutent)FDA Link 05/2009
1	temsirolimus FDA Link 05/2009
1	EndonucleasesIBA 08/2008
1	BuffersIBA 01/2008
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2006
1	CollagenIBA 12/2003

Therapy/Procedure

12	Therapeutics 01/2020 - 01/2007
3	Hysterectomy 01/2019 - 07/2003
1	Precision Medicine 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 12/2014
1	Molecular Targeted Therapy 01/2014
1	Nephrectomy 05/2005